A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

NCT06283134 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

BIOLOGICAL: BioTTT001 hepatic artery infusion
DRUG: toripalimab
DRUG: regorafenib

Sponsor

China Medical University, China

Collaborators

[object Object]